These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiomyopathy mutation (F88L) in troponin T abolishes length dependency of myofilament Ca2+ sensitivity. Reda SM, Chandra M. J Gen Physiol; 2018 Jun 04; 150(6):809-819. PubMed ID: 29776992 [Abstract] [Full Text] [Related]
7. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. Montgomery DE, Tardiff JC, Chandra M. J Physiol; 2001 Oct 15; 536(Pt 2):583-92. PubMed ID: 11600691 [Abstract] [Full Text] [Related]
9. Depressed Frank-Starling mechanism in the left ventricular muscle of the knock-in mouse model of dilated cardiomyopathy with troponin T deletion mutation ΔK210. Inoue T, Kobirumaki-Shimozawa F, Kagemoto T, Fujii T, Terui T, Kusakari Y, Hongo K, Morimoto S, Ohtsuki I, Hashimoto K, Fukuda N. J Mol Cell Cardiol; 2013 Oct 15; 63():69-78. PubMed ID: 23863340 [Abstract] [Full Text] [Related]
11. Developmental increase in β-MHC enhances sarcomere length-dependent activation in the myocardium. Reda SM, Gollapudi SK, Chandra M. J Gen Physiol; 2019 May 06; 151(5):635-644. PubMed ID: 30602626 [Abstract] [Full Text] [Related]
14. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models. Ferrantini C, Coppini R, Pioner JM, Gentile F, Tosi B, Mazzoni L, Scellini B, Piroddi N, Laurino A, Santini L, Spinelli V, Sacconi L, De Tombe P, Moore R, Tardiff J, Mugelli A, Olivotto I, Cerbai E, Tesi C, Poggesi C. J Am Heart Assoc; 2017 Jul 22; 6(7):. PubMed ID: 28735292 [Abstract] [Full Text] [Related]
15. L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain. Reda SM, Gollapudi SK, Chandra M. J Muscle Res Cell Motil; 2016 Dec 22; 37(6):215-223. PubMed ID: 27975185 [Abstract] [Full Text] [Related]
16. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca2+, and activate NFAT and Akt signaling. Robinson P, Sparrow AJ, Patel S, Malinowska M, Reilly SN, Zhang YH, Casadei B, Watkins H, Redwood C. Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H306-H319. PubMed ID: 32618513 [Abstract] [Full Text] [Related]
17. Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling. Robinson P, Liu X, Sparrow A, Patel S, Zhang YH, Casadei B, Watkins H, Redwood C. J Biol Chem; 2018 Jul 06; 293(27):10487-10499. PubMed ID: 29760186 [Abstract] [Full Text] [Related]
18. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity. Parvatiyar MS, Pinto JR. Biochim Biophys Acta; 2015 Feb 06; 1850(2):365-72. PubMed ID: 25450489 [Abstract] [Full Text] [Related]
19. Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Chandra M, Tschirgi ML, Tardiff JC. Am J Physiol Heart Circ Physiol; 2005 Nov 06; 289(5):H2112-9. PubMed ID: 15994854 [Abstract] [Full Text] [Related]
20. Identification of two new regions in the N-terminus of cardiac troponin T that have divergent effects on cardiac contractile function. Mamidi R, Mallampalli SL, Wieczorek DF, Chandra M. J Physiol; 2013 Mar 01; 591(5):1217-34. PubMed ID: 23207592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]